Effects of Saccharomyces cerevisiae subspecies boulardii CNCM I-1079 on feed intake by healthy beef cattle treated with florfenicol and on health and performance of newly received beef heifers

The effects of a live yeast supplement [Saccharomyces cerevisiae subspecies boulardii CNCM I-1079; ProTernative Stress Formula (PTSF) yeast, Ivy Natural Solutions, Overland Park, KS] on DMI, performance, and health of beef cattle were evaluated in 3 experiments. In Exp. 1, a pilot study was conducted with 10 healthy beef steers fed a 65% concentrate diet to evaluate the effects of florfenicol (s.c. in the neck vs. sterile water injection) on DMI. Steers injected with florfenicol had 15.6 (P = 0.092) and 22.2% (P = 0.015) decreases in DMI compared with controls on the day of and day after injection, respectively, with no differences for the remainder of the 7-d period. In the main study of Exp. 1, healthy beef steers (6 pens of 5 steers each/treatment) were fed the control or PTSF yeast diets (0.5 g of yeast x steer(-1) x d(-1)) for 5 d before being injected s.c. with florfenicol. Compared with the 5 d before injection, DMI decreased after injection, but it did not differ (P > 0.66) between treatments on the day of and day after injection. By the second day after injection, DMI tended (P = 0.107) to increase for steers fed PTSF yeast vs. control steers, with a trend for a similar pattern on the third day after injection (P = 0.197). No differences were noted between treatments for the remainder of the 7-d period or for the subsequent 2 wk. In Exp. 2, 3 loads of beef heifers (277 heifers; average initial BW = 230.3 kg) were shipped from auction barns and assigned randomly to 1 of 2 treatments (5 pens/treatment in each load) during 35-d receiving periods: 1) control = 65% concentrate receiving diet; or 2) PTSF yeast = 65% concentrate receiving diet with PTSF yeast added to supply 0.5 g of yeast x heifer(-1) x d(-1). All heifers were treated with florfenicol on arrival, and PTSF yeast heifers received approximately 1 g of yeast via an oral paste at the time of processing. Averaged over the 3 loads, treatments did not affect (P > or = 0.12) DMI, ADG, or G:F during the 35-d period, but the percentage of cattle treated once or more for bovine respiratory disease (BRD) was greater for control (P = 0.04) than for PTSF yeast heifers (24.0 vs. 13.78% respectively). In Exp. 3, 2 loads of beef heifers (180 heifers; average initial BW = 209.0 kg) that were not treated with antibiotic at the time of arrival processing were fed a 70% concentrate receiving diet and assigned the same 2 treatments as in Exp. 2. No differences (P > 0.72) were noted between treatments in ADG, DMI, and G:F for the 35-d receiving period, and BRD morbidity pooled across loads did not differ between treatments (40.2 vs. 33.1% for control vs. PTSF yeast). Providing PTSF yeast in an oral paste at the time of processing combined with the addition of 0.5 g of yeast x animal(-1) x d(-1) in the diet had little effect on receiving period performance; however, it decreased BRD morbidity in heifers given florfenicol on arrival but was without effect on BRD morbidity in heifers that did not receive a prophylactic antibiotic.     

饲喂不同方法处理的高粱对绵羊瘤胃微生物蛋白生产的影响

25只绵羊分成5组，每组5只，每只羊每天喂给苜蓿二草420g，另加用下列方法处理的高粱子实280g：a.未处理的高粱；b.微波处理（1．5g高梁微波处理15min）；c。120℃蒸汽处理10min；d。0．5％洗涤剂浸泡30min；e．水浸泡30min。用嘌呤衍生物在尿中的排泄量估测瘤胃微生物蛋白的产量。瘤胃微生物蛋白产量及其生产效率均未受高粱处理方法的影响。     

The physiological and production effects of increased dietary intake of vitamins E and C in feedlot cattle challenged with bovine herpesvirus 1

The physiological and production effects of feeding additional vitamin E and ruminally protected vitamin C were examined in cattle challenged with bovine herpesvirus 1 (BHV 1). Forty-eight individually penned 6-mo-old Angus and Angus crossbred heifer calves with a mean BW of 151 kg were allocated randomly to four diets in a 2 x 2 factorial arrangement of treatments. Pelleted diets provided either 15 or 185 IU/kg of DM of vitamin E, with or without 3.7 g of ruminally protected vitamin C/kg of DM. Blood samples were taken at start of the experiment and at wk 4, 5, and 6. At the start of wk 5, half of each of the dietary groups was challenged with BHV 1. Feeding additional vitamin E was associated with greater (P < 0.001) mean plasma alpha-tocopherol. In contrast, feeding ruminally protected vitamin C was not associated with greater (P = 0.59) mean plasma ascorbate concentration; however, feeding ruminally protected vitamin C was associated with lower (P = 0.03) mean blood total superoxide dismutase (Cu/Zn SOD and Mn SOD) concentration. Calves fed additional vitamin E had greater (P = 0.05) mean plasma beta-carotene concentrations. There were interactions between dietary intake of vitamins E and C with respect to serum ceruloplasmin concentration (P = 0.01) and G:F (P = 0.05). Bovine herpesvirus 1 challenge was associated with lower white cell count (P = 0.007), lymphocyte count (P < 0.001), and DMI (P = 0.03). Feeding additional vitamin E to calves challenged with BHV 1 was associated with a lower (P = 0.03) serum ceruloplasmin concentration. There was a non-significant trend towards an interaction (P = 0.06) between the feeding of vitamins E and C, with virus-challenged calves fed additional vitamin E alone having greater plasma retinol concentrations. The feeding of vitamins E and/or C in calves challenged with BHV 1 was associated with alterations in the concentrations of other antioxidants. More severe disease may have translated these cellular effects to changes in health and performance.     

Effects of an artificial sweetener on health, performance, and dietary preference of feedlot cattle

Two experiments examined the effects of a saccharin-based artificial sweetener (Sucram) on health, performance, and dietary preference of feedlot cattle. In Exp. 1, 200 steer calves (initial BW = 190.4 +/- 1.47 kg) were fed a 65% concentrate diet supplemented with or without 200 mg of Sucram/kg (DM basis) during a 56-d receiving-growing period. Feeding Sucram did not affect overall (P = 0.19) DMI; however, from d 29 to 56, there was a trend (P = 0.10) for increased DMI with Sucram (5.71 vs. 6.02 kg/d, respectively). From d 0 to 28 and d 0 to 56, there were trends (P = 0.11 and 0.12, respectively) for increased ADG and for increased d-56 BW (P = 0.07) for calves fed Sucram. No differences were detected (P = 0.82) for receiving (REC) period morbidity. During the finishing (FIN) period, 180 steers from the REC period were assigned (9 pens/treatment in a 2 x 2 factorial design) to the following treatments: 1) control REC/control FIN; 2) control REC/Sucram FIN; 3) Sucram REC/control FIN; and 4) Sucram REC/ Sucram FIN. Over the FIN period, ADG tended (P = 0.12) to be greater for Sucram; however, carcass-adjusted ADG did not differ among treatments. Daily DMI was affected by a REC x FIN interaction (P = 0.08), which was the result of greater DMI by cattle in the Sucram REC/Sucram FIN treatment and decreased DMI by cattle in the Sucram REC/control FIN treatment. In general, changes in carcass characteristics were minor. In Exp. 2, 12 steers (initial BW = 395.6 +/- 6.17 kg) were used in a simultaneously replicated 3 x 3 Latin square preference test. Each square consisted of 3 pens, with 2 steers/pen, and 3 time periods. Bunks had dividers at their midpoint, and equal quantities of diet (as-fed basis) were delivered randomly on either side of the divider daily. Treatments were: 1) control; 2) Sucram = basal diet supplemented with 200 mg of Sucram/kg of DM; and 3) choice = control and Sucram on separate sides of the divider. Dietary preference differed on d 1 (P = 0.01) and d 3 (P = 0.02) for control vs. choice and Sucram vs. choice, with the choice group consuming 0.49 and 1.72 kg of DM more of the Sucram diet than the control diet, respectively. This effect, however, was not consistent across days, and average DMI did not differ (P = 0.81) among treatments. Addition of Sucram to the diet of newly received cattle tended to increase receiving period ADG; however, its effects on morbidity, finishing performance, and dietary preference were limited.     

Descriptive epidemiological study of the use of antimicrobial drugs by companion animal veterinarians in New Zealand

Abstract

AIM: To describe the patterns of use of antimicrobial drugs by veterinary surgeons treating commonly presented bacterial infections in companion animals in New Zealand.

METHODS: A postal survey of 800 randomly selected companion animal veterinarians practicing in New Zealand was conducted between August and December 2008. Data were collected regarding the antimicrobials prescribed for recent cases of skin, ear and urinary tract infections; the use of culture and susceptibility testing; and veterinarian characteristics such as proportion of time spent treating companion animals and recent attendance at continuing professional development (CPD) events. Potential associations within the data were explored using extended mosaic plots and multivariable regression models.

RESULTS:Completed surveys from 393 respondents were available for analysis, providing data on systemic antimicrobial drug use for 1,799 cases of presumptive bacterial infections. The most frequently prescribed drugs were amoxicillin-clavulanic acid (864 cases, 48%), cephalexin (558, 31%), and fluoroquinolones (198, 11%). Of 359 cases of canine superficial pyoderma, 157 (44%) were treated with amoxicillin-clavulanic acid and 155 (43%) were treated with cephalexin with median reported treatment durations of 7 and 10 days, for these two drugs respectively. Culture and susceptibility tests had been used in 376 of 1,984 (19%) of all reported cases and 160 (43%) of these were suspected urinary tract infections. Practitioners that spent 100% of their time treating companion animals and who had attended a CPD course related to companion animals within the 12 months prior to completing the survey were more likely to submit a sample for culture and susceptibility testing and to prescribe longer courses of antimicrobials for the treatment of canine pyoderma than practitioners who spent less than 100% of their time treating companion animals and had not attended a CPD course in the last 12 months.

CONCLUSIONS: Broad-spectrum drugs considered by the World Health Organisation to be critically important for human health, such as fluoroquinolones and amoxicillin-clavulanic acid, are amongst the most frequently prescribed antimicrobials in companion animal medicine, and these drugs are often prescribed without submitting a sample for culture and susceptibility testing.

CLINICAL RELEVANCE: Many cases of superficial pyoderma were treated for less than the recommended duration of 21 days, which may contribute to a higher rate of recurrent pyoderma and the development of drug resistance within the causal bacteria. Veterinarians should be aware that the use of fluoroquinolones, in particular, should be based upon the results of a culture and susceptibility test.     

Estimating the level of disease risk and biosecurity on commercial poultry farms in New Zealand

ABSTRACT

Aims: To collect baseline data on the contact risk pathways and biosecurity practices of commercial poultry farms in New Zealand, investigate the relationship between the farm-level disease contact risks and biosecurity practices, and identify important poultry health concerns of producers.

Methods: A cross-sectional survey of all registered New Zealand commercial poultry operations was conducted in 2016 collecting information on farm demographics, biosecurity practices, and contact risk pathways. Survey responses were used to generate an unweighted subjective disease risk score based on eight risk criteria and a subjective biosecurity score based on the frequency with which producers reported implementing seven biosecurity measures. Producer opinions towards poultry health issues were also determined.

Results: Responses to the survey response were obtained from 120/414 (29.0%) producers, including 57/157 (36.3%) broiler, 33/169 (19.5%) layer, 24/55 (44%) breeder, and 6/32 (19%) other poultry production types. Median disease risk scores differed between production types (p?<?0.001) and were lowest for breeder enterprises. The greatest risk for layer and broiler enterprises was from the potential movement of employees between sheds, and for breeder enterprises was the on- and off-farm movement of goods and services. Median biosecurity scores also differed between production types (p?<?0.001), and were highest for breeder and broiler enterprises. Across all sectors there was no statistical correlation between biosecurity scores and disease risk scores. Producers showed a high level of concern over effectively managing biosecurity measures.

Conclusions: The uptake of biosecurity measures in the commercial poultry farms surveyed was highly variable, with some having very low scores despite significant potential disease contact risks. This may be related to the low prevalence or absence of many important infectious poultry diseases in New Zealand leading farmers to believe there is a limited need to maintain good biosecurity as well as farmer uncertainty around the efficacy of different biosecurity measures. Further research is needed to understand barriers towards biosecurity adoption including evaluating the cost-effectiveness of biosecurity interventions.     

Effects of injectable vitamins A, D, E and C on the health and growth rate of feedlot cattle destined for the Australian domestic market

OBJECTIVE: To examine the effects of injectable vitamins A, D and E at feedlot entry on health and growth rate and the effects of injectable vitamin C at the time of treatment for bovine respiratory disease (BRD) on cattle health. DESIGN: Systematic allocation of 2465 cattle at feedlot entry to: a commercial vitamin A, D and E preparation at the label dose rate; commercial vitamin A, D and E at twice the label dose rate; a formulation with no vitamin D, a lower concentration of vitamin A and a higher concentration of vitamin E; and the oil-based carrier alone at volumes corresponding to the above treatments. Comparisons of growth rate, disease and mortality were made between the groups at the conclusion of the feeding period. In a separate experiment, 176 cattle were alternately administered injectable vitamin C at the time of treatment for BRD, or were not injected with vitamin C, and mortality was compared between the groups. RESULTS: There were no differences between cattle administered vitamin A, D and E at feedlot entry and the controls in growth rate (P=0.11), all diseases (P=0.99), BRD (P=0.60) or mortalities (P=0.95). Cattle treated with the higher vitamin E and lower vitamin A preparation had a higher (P=0.02) incidence of anorexia than the other groups. Fewer cattle treated with 5 g of vitamin C by intramuscular injection at the time of treatment with antibiotics for BRD subsequently died (P=0.04). CONCLUSIONS: The routine injection of cattle with vitamins A, D and E at feedlot entry is unlikely to result in improvements in health and growth rate where cattle are provided with these vitamins in their diets at concentrations equal to the National Research Council recommendations. Mortality rate in cattle diagnosed with BRD may be reduced by intramuscular injection of vitamin C at the time of treatment with antibiotics.     

Effects of duration of zilpaterol hydrochloride feeding and days on the finishing diet on feedlot cattle performance and carcass traits

British and British x Continental steers (n = 560; initial BW = 339.4 +/- 1.76 kg) were used in a serial slaughter study with a completely random design to evaluate effects of zilpaterol hydrochloride (ZH; 8.33 mg/kg of dietary DM basis) on performance and carcass characteristics. Treatments were arranged in a 4 x 4 factorial (112 pens; 7 pens/treatment; 5 steers/pen) and included duration of ZH feeding (0, 20, 30, or 40 d before slaughter plus a 3-d ZH withdrawal period) and days on feed (DOF) before slaughter (136, 157, 177, and 198 d). No duration of ZH feeding x slaughter group interactions were detected for the performance measurements (P > 0.10). Final BW did not differ (P = 0.15) between the 0-d group and the average of the 3 ZH groups, but ADG was greater for the average of the 3 ZH groups during the period in which ZH diets were fed (P < 0.01) and for the overall feeding period (P = 0.05). As duration of ZH feeding increased, DMI decreased (P = 0.01) and G:F increased linearly (P < 0.01). With the exception of KPH (P = 0.022), no duration of ZH feeding x slaughter group interactions (P > 0.10) were detected for carcass characteristics. Regardless of the duration of ZH feeding, cattle fed ZH had greater HCW (P < 0.01), greater dressing percent (P < 0.01), less 12th-rib fat (P < 0.01), larger LM area (P < 0.01), less KPH (P = 0.03), and lower yield grade (P < 0.01) than the 0-d cattle. The 0-d group had greater marbling scores (P < 0.01) than cattle fed ZH diets, with a tendency for a linear decrease in marbling score (P = 0.10) as duration of ZH feeding was extended. A greater percentage of carcasses in the 0-d group graded USDA Choice or greater (P < 0.01) than in the 3 ZH groups, whereas the percentage of Select carcasses was greater (P = 0.01) for the 3 ZH groups. From d 0 to end (P = 0.04) and during the last 43 d on feed (P < 0.01), ADG responded quadratically to DOF before slaughter. No differences were detected among slaughter groups for DMI for the entire trial period; however, a quadratic response (P = 0.02) was observed for the final 43 d before slaughter. A quadratic response was also detected for the final 43 d before slaughter (P < 0.01) and from d 0 to end (P = 0.02) for G:F. Final BW, HCW, dressing percent, and 12th-rib fat increased linearly (P < 0.01) as DOF before slaughter increased. Our results indicate that no substantial effects on performance and carcass measurements were observed when ZH was fed for 30 or 40 d as opposed to 20 d, and that effects of ZH generally did not interact with DOF before slaughter.